Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.

Cornuz J, Gilbert A, Pinget C, McDonald P, Slama K, Salto E, Paccaud F.

Tob Control. 2006 Jun;15(3):152-9.

2.

Cost-effectiveness analysis of the first-line therapies for nicotine dependence.

Cornuz J, Pinget C, Gilbert A, Paccaud F.

Eur J Clin Pharmacol. 2003 Jul;59(3):201-6. Epub 2003 May 21.

PMID:
12759795
3.

The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.

Gilbert AR, Pinget C, Bovet P, Cornuz J, Shamlaye C, Paccaud F.

Tob Control. 2004 Jun;13(2):190-5.

4.

[Economic evaluation of pharmacotherapies for smoking cessation].

Antoñanzas F, Portillo F.

Gac Sanit. 2003 Sep-Oct;17(5):393-403. Spanish.

5.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
6.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
7.

Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.

Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.

PMID:
22818870
8.

The cost-effectiveness of the nicotine transdermal patch for smoking cessation.

Wasley MA, McNagny SE, Phillips VL, Ahluwalia JS.

Prev Med. 1997 Mar-Apr;26(2):264-70.

PMID:
9085397
9.

Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.

Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Mölken MP.

Value Health. 2005 May-Jun;8(3):178-90.

10.
11.
12.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
13.

Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.

Pinget C, Martin E, Wasserfallen JB, Humair JP, Cornuz J.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):451-5.

PMID:
17568248
14.

Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.

Taylor M, Leonardi-Bee J, Agboola S, McNeill A, Coleman T.

Addiction. 2011 Oct;106(10):1819-26. doi: 10.1111/j.1360-0443.2011.03493.x. Epub 2011 Jul 27.

PMID:
21561499
16.

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.

Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N.

Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S26-37. Review.

PMID:
12369228
17.

Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.

Javitz HS, Swan GE, Zbikowski SM, Curry SJ, McAfee TA, Decker DL, Patterson R, Jack LM.

Am J Manag Care. 2004 Mar;10(3):217-26.

18.

Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.

Linden K, Jormanainen V, Linna M, Sintonen H, Wilson K, Kotomäki T.

Curr Med Res Opin. 2010 Mar;26(3):549-60. doi: 10.1185/03007990903542666.

PMID:
20050814
19.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

20.

Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.

Higashi H, Barendregt JJ.

Addiction. 2012 Mar;107(3):658-70. doi: 10.1111/j.1360-0443.2011.03632.x. Epub 2011 Nov 1.

PMID:
21883602
Items per page

Supplemental Content

Write to the Help Desk